BR9710689A - Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia - Google Patents

Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia

Info

Publication number
BR9710689A
BR9710689A BR9710689A BR9710689A BR9710689A BR 9710689 A BR9710689 A BR 9710689A BR 9710689 A BR9710689 A BR 9710689A BR 9710689 A BR9710689 A BR 9710689A BR 9710689 A BR9710689 A BR 9710689A
Authority
BR
Brazil
Prior art keywords
diarrhea
mammal
reducing
symptoms
treating acute
Prior art date
Application number
BR9710689A
Other languages
English (en)
Inventor
Ivan A Casas
Bo Moellstam
Original Assignee
Biogaia Biolog Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Biolog Ab filed Critical Biogaia Biolog Ab
Publication of BR9710689A publication Critical patent/BR9710689A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9710689A 1996-06-05 1997-06-03 Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia BR9710689A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/658,473 US5837238A (en) 1996-06-05 1996-06-05 Treatment of diarrhea
PCT/US1997/009626 WO1997046104A1 (en) 1996-06-05 1997-06-03 Treatment of diarrhea

Publications (1)

Publication Number Publication Date
BR9710689A true BR9710689A (pt) 1999-08-17

Family

ID=24641378

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710689A BR9710689A (pt) 1996-06-05 1997-06-03 Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia

Country Status (12)

Country Link
US (1) US5837238A (pt)
EP (1) EP0923293B1 (pt)
JP (2) JP2000512634A (pt)
AT (1) ATE281840T1 (pt)
AU (1) AU734194B2 (pt)
BR (1) BR9710689A (pt)
CA (1) CA2257077C (pt)
DE (1) DE69731540T2 (pt)
ES (1) ES2232869T3 (pt)
PL (1) PL189998B1 (pt)
PT (1) PT923293E (pt)
WO (1) WO1997046104A1 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6399055B1 (en) * 1998-10-27 2002-06-04 Compagnie Gervais Danone Method and composition for treatment of infant diarrhea
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
CZ20013269A3 (cs) 1999-03-11 2002-04-17 Société des Produits Nestlé S. A. Bakterie mléčného kvaąení
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
US6283294B1 (en) * 1999-09-01 2001-09-04 Biogaia Biologics Ab Enclosed living cell dispensing tube
WO2001098516A2 (en) * 2000-06-19 2001-12-27 Regents Of The University Of Minnesota Siderophores-producing bifidobacteria thereby and uses thereof
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
KR100437497B1 (ko) 2001-03-07 2004-06-25 주식회사 프로바이오닉 로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
US20040071793A1 (en) * 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US7517681B2 (en) * 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
US6872565B2 (en) 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
WO2005041657A1 (en) 2003-10-20 2005-05-12 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US20060078546A1 (en) * 2004-10-07 2006-04-13 Anders Zachrisson Use of lactic acid bacteria to reduce sick time
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US8603460B2 (en) * 2006-06-05 2013-12-10 Brogaia AB Method of making a Lactobacillus reuteri with increased acid tolerance
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
US20110014324A1 (en) * 2009-07-10 2011-01-20 Christoffer Lundqvist Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution
DK3564357T3 (da) 2010-02-01 2022-06-20 Rebiotix Inc Bakterieterapi mod clostridium difficile colitis
US20110293710A1 (en) 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
KR20130098320A (ko) 2010-08-04 2013-09-04 토마스 줄리어스 보로디 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
EP2683390B1 (en) 2011-03-09 2017-05-03 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
EP2674162A1 (en) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
KR20150027152A (ko) * 2012-05-29 2015-03-11 다누타 크루셰프스카 인간 및 동물 모두에서 예방 및 의약에 유용한 락토바실러스 류테리 ｄａｎ080을 포함하는 나노프로덕트 및 이의 의학적 용도
EP4234011A3 (en) 2013-06-05 2023-09-20 Rebiotix, Inc. Microbiota restoration therapy (mrt), compositions and methods of manufacture
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
EP3294307A4 (en) 2015-05-14 2019-01-23 Crestovo Holdings Llc COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
NZ776366A (en) 2015-05-22 2023-02-24 Univ Minnesota Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
AU2018250206A1 (en) 2017-04-05 2019-10-31 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (PD) and related disorders
AU2018272048B2 (en) 2017-05-26 2024-04-04 Finch Therapeutics Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
EP3664823B1 (en) 2017-08-07 2024-06-05 Finch Therapeutics Holdings LLC Composition for use in preventing or treating an enterococcal blood stream infection
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CA3114423A1 (en) 2018-09-27 2020-04-02 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
WO2024081219A1 (en) 2022-10-14 2024-04-18 Csp Technologies, Inc. Container and method for storing and stabilizing moisture sensitive products

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582180D1 (de) * 1984-02-09 1991-04-25 Royal Children S Hospital Rese Lebender attenuierter menschlicher rotavirus-impfstoff und herstellung desselben.
AU5791586A (en) * 1985-05-29 1986-12-04 Pioneer Hi-Bred International, Inc. Treating gastro-intestinal disease in animals
DE3856591D1 (de) * 1987-05-01 2006-08-24 Biogaia Biolog Ab Reuterin enthaltende Nährungszusammensetzung
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5480641A (en) * 1990-06-15 1996-01-02 Biogaia Ab Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract
JPH05292947A (ja) * 1992-04-17 1993-11-09 Sanei Touka Kk ラクトバチルス・アシドフィルスｐｎ−ｒｉ−２−４、それを用いた乳酸菌製剤及びその製造方法
ES2199305T3 (es) * 1995-12-21 2004-02-16 Biogaia Ab Uso de lactobacillus reuteri para inhibir criptosporidiosis en mamiferos.

Also Published As

Publication number Publication date
DE69731540T2 (de) 2005-10-27
EP0923293A1 (en) 1999-06-23
EP0923293A4 (en) 2001-11-07
ATE281840T1 (de) 2004-11-15
WO1997046104A1 (en) 1997-12-11
DE69731540D1 (de) 2004-12-16
PT923293E (pt) 2005-03-31
JP2000512634A (ja) 2000-09-26
ES2232869T3 (es) 2005-06-01
PL189998B1 (pl) 2005-10-31
JP2010265303A (ja) 2010-11-25
CA2257077A1 (en) 1997-12-11
EP0923293B1 (en) 2004-11-10
US5837238A (en) 1998-11-17
AU734194B2 (en) 2001-06-07
PL330324A1 (en) 1999-05-10
JP4861500B2 (ja) 2012-01-25
CA2257077C (en) 2008-10-07
AU3154897A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
NZ210194A (en) Pentapeptides with thymopoietin and splenin like activity
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
CA2265464A1 (en) Therapy for .alpha.-galactosidase a deficiency
CA2187803A1 (en) Methods of treating disease using sertoli cells and allografts or xenografts
BG103429A (en) Methods and compositions for neurone growth stimulation
AU2723295A (en) Method and compositions for stimulating the differentiation of preadipocytic cells and associated therapeutic treatments
FI971420A0 (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
CA2155009A1 (en) Prevention and Treatment of Myocardial Failure
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
AU5323396A (en) Methods of treating inflammation and compositions therefor
KR890701099A (ko) 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질
CA2288650A1 (en) A method for the treatment of mental illness in mammals and a composition therefor
ATE335497T1 (de) Verbesserte methode zur behandlung von säugetieren mit geändertes säugetierblut
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
ES2117717T3 (es) Tratamiento de tumores con factores neurotroficos e inhibidores de la proliferacion celular.
EP0797994A3 (en) Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings
AU4530796A (en) Treating disorders characterised by excessive cell proliferation with sclareolide
EP0904094A4 (en) TREATMENT OF BONE DISEASES USING ADRENOMEDULLINE
BR9807980A (pt) Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva
EP0321094A3 (en) Treatment of factor viii inhibitors
DE69534740D1 (en) Analoge des thymosin alpha 1

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 37 DA LEI 9279/96, INDEFIRO O PRESENTE PEDIDO COM BASE NO ARTIGO 8O EM COMBINACAO COM O ARTIGO 13 DA LEI 9279/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]